Chemokines and tuberculosis

This publication has 65 references indexed in Scilit:

• In Situ Studyof Abundant Expression of Proinflammatory Chemokines and Cytokines inPulmonary Granulomas That Develop in Cynomolgus MacaquesExperimentally Infected withMycobacteriumtuberculosis
  Infection and Immunity, 2003
• Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
  New England Journal of Medicine, 2001
• Activation of β‐Chemokines and CCR5 in Persons Infected with Human Immunodeficiency Virus Type 1 and Tuberculosis
  The Journal of Infectious Diseases, 2001
• Expression of IFN-γ–inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases
  Journal of Allergy and Clinical Immunology, 2001
• Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
  Annual Review of Immunology, 2001
• The Role of Chemokine Receptors in Primary, Effector, and Memory Immune Responses
  Annual Review of Immunology, 2000
• Regulation of CCR5 and CXCR4 Expression by Type 1 and Type 2 Cytokines: CCR5 Expression Is Downregulated by IL-10 in CD4-Positive Lymphocytes
  Clinical Immunology, 1999
• Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in mice
  Immunity, 1995
• Disseminated tuberculosis in interferon gamma gene-disrupted mice.
  The Journal of Experimental Medicine, 1993
• Immunopathology of leprosy granulomas
  Springer Seminars in Immunopathology, 1988